Literature DB >> 25843298

Direct costs of unintended pregnancy in Spain.

Iñaki Lete1, Fareen Hassan, Ismini Chatzitheofilou, Eifiona Wood, Joan Mendivil, Dimitra Lambrelli, Anna Filonenko.   

Abstract

OBJECTIVE: The aim of the study was to estimate the burden and direct medical costs of unintended pregnancy to the public payer in Spain.
METHODS: An economic model evaluating the costs and outcomes of contraceptive use over a 1-year period was constructed for women in Spain aged 15 to 44 years at risk of pregnancy. Model inputs were derived from published literature and national survey data. Outcomes evaluated included: (i) the annual number of unintended pregnancy events and their cost; (ii) the proportion of unintended pregnancy events and their cost due to non-adherence; and (iii) the use and cost of contraceptive methods in Spain.
RESULTS: Of the total number of pregnancies, 35% are estimated to be unintended and are associated with a direct cost burden of €292.8 million per year. Most unintended pregnancies (26%) occur in women aged 30 to 34 years, whilst 69% of the total cost burden is estimated to be attributable to poor adherence to contraceptive methods.
CONCLUSIONS: The cost associated with unintended pregnancy is high. The major proportion of the burden is estimated to be attributable to imperfect adherence and is likely avoidable. Shifts in patterns of contraceptive use, combined with measures to improve adherence, could have a substantial and positive impact on this burden.

Entities:  

Keywords:  Adherence; Compliance; Contraception; Cost savings; Unintended pregnancy

Mesh:

Year:  2015        PMID: 25843298     DOI: 10.3109/13625187.2015.1028617

Source DB:  PubMed          Journal:  Eur J Contracept Reprod Health Care        ISSN: 1362-5187            Impact factor:   1.848


  7 in total

1.  Induced abortion in a Southern European region: examining inequalities between native and immigrant women.

Authors:  Elena Rodriguez-Alvarez; Luisa N Borrell; Yolanda González-Rábago; Unai Martín; Nerea Lanborena
Journal:  Int J Public Health       Date:  2016-02-22       Impact factor: 3.380

2.  Results of the National Contraception Survey Conducted by Sociedad Española de Contracepción (2020).

Authors:  Fatima Leon-Larios; José Gutiérrez Ales; María José Puente Martínez; Marta Correa Rancel; Isabel Lahoz Pascual; Isabel Silva Reus; José Cruz Quílez Conde
Journal:  J Clin Med       Date:  2022-06-29       Impact factor: 4.964

3.  Economic Burden of Contraception Management in Spain.

Authors:  Inmaculada Parra Ribes; Juan José Rascón Poza; Ezequiel Pérez Campos; Ignacio Bugella Yudice; Maria Jesús Rodríguez Domingo
Journal:  J Health Econ Outcomes Res       Date:  2018-04-16

4.  Impact of Unintended Pregnancy on Maternal and Neonatal Outcomes.

Authors:  Reza Omani-Samani; Mehdi Ranjbaran; Maryam Mohammadi; Arezoo Esmailzadeh; Mahdi Sepidarkish; Saman Maroufizadeh; Amir Almasi-Hashiani
Journal:  J Obstet Gynaecol India       Date:  2018-05-16

5.  The effectiveness of a digital shared decision-making tool in hormonal contraception during clinical assessment: study protocol of a randomized controlled trial in Spain.

Authors:  Maria Inmaculada de Molina-Férnandez; Laia Raigal-Aran; Miriam de la Flor-Lopez; Paula Prata; Isabel Font-Jimenez; Francesc Valls-Fonayet; Gemma March-Jardi; Ramon Escuriet-Peiro; Lourdes Rubio-Rico
Journal:  BMC Public Health       Date:  2019-09-04       Impact factor: 3.295

6.  Development of a pharmacoeconomic registry: an example using hormonal contraceptives.

Authors:  Annesha White; Meenakshi Srinivasan; La Marcus Wingate; Samuel Peasah; Marc Fleming
Journal:  Health Econ Rev       Date:  2021-03-20

7.  Contraceptive counselling experiences in Spain in the process of creating a web-based contraceptive decision support tool: a qualitative study.

Authors:  Laura Reyes-Martí; Lourdes Rubio-Rico; Laura Ortega-Sanz; Laia Raigal-Aran; Miriam de la Flor-López; Alba Roca-Biosca; Francesc Valls-Fonayet; Montse Moharra-Francés; Ramon Escuriet-Peiro; María Inmaculada de Molina-Fernández
Journal:  Reprod Health       Date:  2021-11-27       Impact factor: 3.223

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.